Table 1

Demographics and clinical characteristics of the two study groups
Demographic/clinical characteristics Training group p value Testing group p value
EGF DGF EGF DGF
Patients (n) 7 7 5 5
Gender (M/F) 4/3 3/4 n.s. 2/3 3/2 n.s.
Recipient age (years) 47.1 ± 9.3 48.3 ± 8.4 n.s. 46.3 ± 10.1 47.7 ± 7.5 n.s.
Donor age (years) 47.3 ± 9.3 51.9 ± 12.6 n.s. 49.1 ± 6.4 49.5 ± 5.9 n.s.
Donor cause of death (trauma/others) 3/4 3/4 n.s. 2/3 2/3 n.s.
HLA mismatches (n) 3.4 ± 1.2 3.5 ± 0.8 n.s. 3.4 ± 1.1 3.5 ± 0.9 n.s.
Cold ischemia time (h) 12.1 ± 3.8 17.4 ± 5.1 <0.05 11.2 ± 2.3 16.8 ± 4.3 0.01
Length of DGF (days) 0 17.8 ± 12.8 <0.001 0 14.2 ± 16.3 <0.001

EGF, early graft function; DGF, delayed graft function; HLA, human leukocyte antigen. Values are expressed as mean±SD. P-value calculated by T-test and Chi-square test.

Zaza et al.

Zaza et al. BMC Medical Genomics 2014 7:14   doi:10.1186/1755-8794-7-14

Open Data